title: Pioglitazone associated diabetic macular oedema.
authors: G
authors: G
authors: Gokce
authors: A H
authors: AH
authors: Durukan
authors: F C
authors: FC
authors: Erdurman
authors: O M
authors: OM
authors: Ceylan
authors: G
authors: G
authors: Sobaci
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage; D000068258:Bevacizumab; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D058449:Intravitreal Injections; D008269:Macular Edema / Q000139:chemically induced* / Q000188:drug therapy; D008875:Middle Aged; D000077205:Pioglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*; D017211:Treatment Failure
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000068258:Bevacizumab; D000077205:Pioglitazone